Ehsan Sadri is an Ophthalmology physician affiliated with Visionary Pharmaceuticals. OpenAlex indexes 13 publications with 290 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
361 Hospital Rd
Suite 327
Newport Beach, CA 926633522
Telephone
949-642-3100Registry record last updated 15 Aug 2012.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tarsus Pharmaceuticals, Inc.Program year20253 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202512 payments
- Alcon Research LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
58%Corticosteroid18.1%Prednisolone Acetate91%Fluorometholone7%Hydrocortisone3%Part D≥330 patientsProstaglandin Analog17.5%Latanoprost87%Lumigan6%Tafluprost4%Travoprost3%Part D<11 patients+ 8 more classes in this area
Musculoskeletal
13%Cyclooxygenase Inhibitor13%Ketorolac Tromethamine100%Part D≥264 patientsAnti-infectives
12.4%Fluoroquinolone Antibacterial12.4%Moxifloxacin100%Part D≥248 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase 1 Study of OcuRing-K™ (Ketorolac Ophthalmic Implant) in Subjects Undergoing Cataract Surgery2021
- Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial
American Journal of Ophthalmology
2019 - Comparison of Delivery Forces and Wound Dimensions of New Smaller Incision Injector for Plate-Haptic Intraocular Lens
Investigative Ophthalmology & Visual Science
2019 - Subjective Outcomes Evaluation of Aspheric Diffractive and Apodized Diffractive Aspheric Multifocal IOLs
Investigative Ophthalmology & Visual Science
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”